Friday, July 21, 2017

Kalbitor Approved for Treatment of Hereditary Angiodema (HAE)

FDA Approves Kalbitor for Treating Potentially Life-Threatening Attacks of Hereditary Angioedema The U.S. Food and Drug Administration approved Kalbitor (ecallantide) on Dec. 1 to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE). HAE is caused by a defect in the blood […]

READ COMPLETE ARTICLE »

New Flu Vaccine Approved: Agriflu Seasonal Flu Vaccine

The U.S. Food and Drug Administration (FDA) today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B. Agriflu is not intended to protect against the 2009 H1N1 influenza. Agriflu, manufactured by Novartis Vaccines and Diagnostics in Siena, Italy, was approved using the FDA’s accelerated […]

READ COMPLETE ARTICLE »

Plavix Warning: Avoid Use with Prilosec, Says FDA

Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17. New data suggest that when patients take both Prilosec and Plavix, Plavix’s ability to block platelet aggregation (anti-clotting effect) may be reduced by about half. “Both of these […]

READ COMPLETE ARTICLE »

Shingles Pain Relief Drug Approved by FDA

The Food and Drug Administration (FDA) has announced the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia (PHN), a serious complication that can occur after a bout with shingles. The drug is approved for long-term pain relief after shingles attacks. Shingles is an outbreak of rash […]

READ COMPLETE ARTICLE »